Lecithinum-Injeel Forte Liq (6d,10d,30d,200d/1.1ml) 6 D / 1.1 mL Liquid is a Health Canada–registered human drug (DIN 02052105) held by Biologische Heilmittel Heel GmbH, containing Phosphatidyl Choline. Health Canada lists its status as Cancelled Post Market (status date 07 Mar 1997). Nexara Health has matched 1 registration of Phosphatidyl Choline across 1 other regulated market.
Health Canada registration
| DIN | 02052105 |
|---|---|
| Brand name | Lecithinum-Injeel Forte Liq (6d,10d,30d,200d/1.1ml) |
| Active ingredient | Phosphatidyl Choline |
| Strength | 6 D / 1.1 mL |
| Dosage form | Liquid |
| Route | Oral |
| Company | Biologische Heilmittel Heel GmbH |
| Status | Cancelled Post Market — 07 Mar 1997 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Phosphatidyl Choline registered in other markets
1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Malaysia | Avance PhosChol 565 | Best World Lifestyle Sdn. Bhd. | Health Supplement | PRODUCT APPROVED | NPRA |
See every manufacturer of Phosphatidyl Choline worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Lecithinum-Injeel Forte Liq (6d,10d,30d,200d/1.1ml) (DIN 02052105) marketed in Canada?
No. Health Canada lists DIN 02052105 as Cancelled Post Market as of 07 Mar 1997.
Who holds the Canadian licence for this product?
Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.
Is Phosphatidyl Choline registered outside Canada?
Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02052105, status date 1997-03-07; national medicine registries: NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02052105, status date 1997-03-07; national medicine registries: NPRA.
Health Canada Drug Product Database (DPD), DIN 02052105, status date 1997-03-07; national medicine registries: NPRA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.